Literature DB >> 32246442

Coronary Artery Disease: From Mechanism to Clinical Practice.

Chunli Shao1, Jingjia Wang1, Jian Tian1, Yi-da Tang2.   

Abstract

In most developed countries, coronary artery disease (CAD), mostly caused by atherosclerosis of coronary arteries, is one of the primary causes of death. From 1990s to 2000s, mortality caused by acute MI declined up to 50%. The incidence of CAD is related with age, gender, economic, etc. Atherosclerosis contains some highly correlative processes such as lipid disturbances, thrombosis, inflammation, vascular smooth cell activation, remodeling, platelet activation, endothelial dysfunction, oxidative stress, altered matrix metabolism, and genetic factors. Risk factors of CAD exist among many individuals of the general population, which includes hypertension, lipids and lipoproteins metabolism disturbances, diabetes mellitus, chronic kidney disease, age, genders, lifestyle, cigarette smoking, diet, obesity, and family history. Angina pectoris is caused by myocardial ischemia in the main expression of pain in the chest or adjoining area, which is usually a result of exertion and related to myocardial function disorder. Typical angina pectoris would last for minutes with gradual exacerbation. Rest, sit, or stop walking are the usual preference for patients with angina, and reaching the maximum intensity in seconds is uncommon. Rest or nitroglycerin usage can relieve typical angina pectoris within minutes. So far, a widely accepted angina pectoris severity grading system included CCS (Canadian Cardiovascular Society) classification, Califf score, and Goldman scale. Patients with ST-segment elevated myocardial infarction (STEMI) may have different symptoms and signs of both severe angina pectoris and various complications. The combination of rising usage of sensitive MI biomarkers and precise imaging techniques, including electrocardiograph (ECG), computed tomography, and cardiac magnetic resonance imaging, made the new MI criteria necessary. Complications of acute myocardial infarction include left ventricular dysfunction, cardiogenic shock, structural complications, arrhythmia, recurrent chest discomfort, recurrent ischemia and infarction, pericardial effusion, pericarditis, post-myocardial infarction syndrome, venous thrombosis pulmonary embolism, left ventricular aneurysm, left ventricular thrombus, and arterial embolism.

Entities:  

Keywords:  Clinical presentation; Complication; Epidemiology; Pathophysiology; Risk factors

Year:  2020        PMID: 32246442     DOI: 10.1007/978-981-15-2517-9_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  24 in total

Review 1.  Recent updates on novel therapeutic targets of cardiovascular diseases.

Authors:  Muhammad Afzal
Journal:  Mol Cell Biochem       Date:  2020-08-26       Impact factor: 3.396

Review 2.  Transformational Applications of Human Cardiac Organoids in Cardiovascular Diseases.

Authors:  Wanling Xuan; Srinivas M Tipparaju; Muhammad Ashraf
Journal:  Front Cell Dev Biol       Date:  2022-06-09

Review 3.  Emerging roles of SIRT6 in human diseases and its modulators.

Authors:  Gang Liu; Haiying Chen; Hua Liu; Wenbo Zhang; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-16       Impact factor: 12.944

4.  Associations between coronary heart disease and risk of cognitive impairment: A meta-analysis.

Authors:  Xuan Liang; Yilin Huang; Xu Han
Journal:  Brain Behav       Date:  2021-03-20       Impact factor: 2.708

5.  Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension.

Authors:  Shu-Yang Li; Yoichi Yoshida; Eiichi Kobayashi; Akihiko Adachi; Seiichiro Hirono; Tomoo Matsutani; Seiichiro Mine; Toshio Machida; Mikiko Ohno; Eiichiro Nishi; Yoshiro Maezawa; Minoru Takemoto; Koutaro Yokote; Kenichiro Kitamura; Makoto Sumazaki; Masaaki Ito; Hideaki Shimada; Hirotaka Takizawa; Koichi Kashiwado; Go Tomiyoshi; Natsuko Shinmen; Rika Nakamura; Hideyuki Kuroda; Xiao-Meng Zhang; Hao Wang; Kenichiro Goto; Yasuo Iwadate; Takaki Hiwasa
Journal:  Int J Mol Med       Date:  2020-07-29       Impact factor: 4.101

6.  Effect of Lentivirus-Mediated miR-499a-3p on Human Umbilical Vein Endothelial Cells.

Authors:  Huilei Zheng; Juan Li; Ying Chen; Danping Gong; Jianlin Wen; Lanxian Mai; Zhiyu Zeng
Journal:  Biomed Res Int       Date:  2020-08-26       Impact factor: 3.411

7.  Apoptosis in HUVECs induced by microRNA-616-3p via X-linked inhibitor of apoptosis protein targeting.

Authors:  Hua Chen; Xi Liu; Yun Wu; Xiayin Wu; Xiaoli Wen; Yanan Lu; Xingsheng Zhao
Journal:  Exp Ther Med       Date:  2021-04-21       Impact factor: 2.447

8.  Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression.

Authors:  Hui Chen; Zixian Wang; Min Qin; Bin Zhang; Lu Lin; Qilin Ma; Chen Liu; Xiaoping Chen; Hanping Li; Weihua Lai; Shilong Zhong
Journal:  Front Mol Biosci       Date:  2021-04-14

9.  Risk factors for acute pulmonary embolism in patients with off-pump coronary artery bypass grafting: implications for nursing.

Authors:  Jinli Zhou; Xiuhong Cao; Yeping Du; Yan Shi; Weiwei Pan; Suhong Jia
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

10.  Analysis of the association and predictive value of hyperhomocysteinaemia for obstructive coronary artery disease.

Authors:  Hao-Yu Wu; Tian-Jiao Gao; Yi-Wei Cao; Jia-Yu Diao; Peng-Hua You; Xiao-Wei Yao
Journal:  J Int Med Res       Date:  2021-07       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.